Related Experiment Video
Updated: Apr 17, 2026
08:21
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
2.2K
[Experimental study of dicholine succinate pharmacokinetics]
Eksperimental'Naia I Klinicheskaia Farmakologiia
|February 12, 2015
Summary
This study investigated the pharmacokinetics of dicholine succinate (DCS) in rats. Researchers quantified DCS and its metabolites, revealing dose-dependent blood plasma levels, bioavailability, distribution, and excretion pathways.
Area of Science:
- Pharmacology
- Drug Metabolism
- Toxicology
Background:
- Dicholine succinate (DCS) is a compound with potential therapeutic applications.
- Understanding its pharmacokinetic profile is crucial for safe and effective use.
- Limited data exists on DCS pharmacokinetics following different administration routes.
Purpose of the Study:
- To investigate the pharmacokinetics of dicholine succinate (DCS) in rats.
- To quantitatively evaluate DCS and its metabolites across various administration routes.
- To characterize key pharmacokinetic parameters of DCS.
Main Methods:
- Experimental pharmacokinetic study in a rat model.
- Quantitative analysis of DCS and metabolites using radioactive isotope labeling.
- Assessment of dose-dependent drug concentration in blood plasma.
- Determination of total bioavailability and distribution kinetics.
- Identification of primary excretion routes for DCS.
Main Results:
- Established the dose-dependent relationship between DCS administration and blood plasma concentrations.
- Determined the total bioavailability of DCS following different administration routes.
- Characterized the distribution kinetics of DCS within the rat body.
- Identified the main pathways for DCS excretion.
- Provided the first experimental pharmacokinetic data for DCS in rats.
Conclusions:
- The study provides a comprehensive pharmacokinetic profile of dicholine succinate in rats.
- Findings elucidate dose-dependency, bioavailability, distribution, and excretion of DCS.
- This research lays the groundwork for future clinical investigations and therapeutic applications of DCS.
More Related Videos
05:27Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools
Published on: July 20, 2022
2.3K
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
13.2K
Related Concept Videos
01:19Depolarizing Blockers: Pharmocokinetics
744
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
744
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
2.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.1K
01:24Cholinergic Antagonists: Pharmacokinetics
1.1K
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
1.1K
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.8K
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
106
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
106
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
355
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
355